GHRP-2: adverse events and evidence limits
Acute IV GHRP-2 tests in six healthy adults aged 22–27 showed prolactin, ACTH and cortisol increases. [1]
These are hormonal measurements; the read abstract does not establish clinical adverse-event frequencies. [1]
What the studies reported
| Effect | Model or participants | How often or as described | Source |
|---|---|---|---|
| Prolactin increase | Six healthy adults aged 22–27, acute intravenous tests | Observed; this is a hormonal measurement, not a clinical adverse-event frequency | [1] |
| ACTH increase | The same participants | Observed; a hormonal measurement — clinical adverse-event frequencies are not established | [1] |
| Cortisol increase | The same participants | Observed; a hormonal measurement — clinical adverse-event frequencies are not established | [1] |
References
- E Arvat et al. (1997). Effects of GHRP-2 and hexarelin, two synthetic GH-releasing peptides, on GH, prolactin, ACTH and cortisol levels in man. Comparison with the effects of GHRH, TRH and hCRH https://doi.org/10.1016/S0196-9781(97)00016-8.